Susan Hasty, Publisher
Table of Contents . . . June 10th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Therapy - New guidelines developed for Pneumocystis pneumonia prophylaxis
HIV Transmission - DC-SIGN intercellular interactions not crucial for transmission
AIDS and HIV Therapy - Simplified antiretroviral regimen safe, effective
Coinfection - Protease inhibitors may reduce hepatitis C load in people coinfected with HIV
Heart Disease - HIV Tat protein can trigger cardiac mitochondrial damage
Preventive Medicine - Novel contraceptive antimicrobial agent can prevent pregnancy, STDs
AIDS and HIV Tuberculosis - Both infections associated with reduced (gamma) {{delta}} T-cell counts
Advocacy - Christian leaders challenge America's response to the AIDS pandemic
Drug Development - Company highlights pharmaceutical product developments at annual meeting
Finance - First quarter 2002 performance: net loss of $0.29 per share
Finance - First quarter net loss: $0.02 per share
Finance - First quarter net loss: $0.09 per share
HIV Genomics - Sam68 expression can restore some Rev function in infected astrocytes
HIV Prevention - Vaccine research is 'best hope' for controlling AIDS pandemic
Medication Safety - GlaxoSmithKline alerts patients, pharmacists, physicians to watch for incorrectly labeled Combivir
Mergers and Acquisitions - Dimethaid Research completes purchase agreement for Oxo Chemie AG
Pharmacy Reimbursement - AIDS drug program stops new enrollments
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.